It is a GLP-1 receptor agonist that reduces appetite, by slowing digestion, leading to weight loss
Both Semaglutide GLP-1 (Ozempic and Wegovy) and Tirzepatide (Mounjaro) were originally created for use in treatment for those with type 2 diabetes to help manage the condition but were quickly realized to have fantastic weight loss benefits as well, which is why they are both so frequently used as part of weight loss treatments
Using 2mL gives you 2.5mg/mL concentration (20 IU = 0.5mg), while 2.5mL gives 2mg/mL (25 IU = 0.5mg)
If it means more hair for years, I am willing to swallow the pills, to use the serum, to swear off ponytails
Interestingly, the 2022 trial revealed that any benefits that persisted after quitting depended on the magnitude of the initial weight loss
Developed as a treatment for managing Type 2 diabetes, these medications have become household names in health and wellness circles as well